| Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects (NCT01994668) | Pfizer | 2014-01-01 |
| A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP) (NCT02110225) | Dompé Farmaceutici S.p.A | 2014-01-01 |
| Early Evaluation of the MAMAACT Trial (NCT04261400) | University of Copenhagen | 2014-01-01 |
| A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of JNJ-42165279 in Healthy Male Participants (NCT02065739) | Janssen Pharmaceutica N.V., Belgium | 2014-01-01 |
| AZD3293 Thorough QT Study in Healthy Male Volunteers (NCT02040987) | AstraZeneca | 2014-01-01 |
| Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults (NCT02051335) | AstraZeneca | 2014-01-01 |
| Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction (NCT02027454) | ViiV Healthcare | 2014-01-01 |
| Muscle Progenitor Cell Therapy for Urinary Incontinence (NCT01953315) | Wake Forest University | 2014-01-01 |
| A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer (NCT02038699) | Jazz Pharmaceuticals | 2014-01-01 |
| Effects of Intake of a Polysaccharides Mix on Metabolism, Hormones and Satiety in Obese Children. (NCT02148614) | Azienda Ospedaliera Universitaria Integrata Verona | 2014-01-01 |
| The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency (NCT02020434) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2014-01-01 |
| FastFES Gait Training for Stroke Patients: Efficacy of Pre-Commercial Device (NCT02032329) | customKYnetics | 2014-01-01 |
| Bone Marrow Transplant With Abatacept for Non-Malignant Diseases (NCT01917708) | Emory University | 2014-01-01 |
| Study of TCM Syndrome of Hepatocellular Carcinoma and Colorectal Cancer Based on System Science (NCT03189992) | Shanghai University of Traditional Chinese Medicine | 2014-01-01 |
| Autologous Stem Cells Transplantation in Patients With Idiopathic and Drug Induced Premature Ovarian Failure (NCT02043743) | El-Rayadh Fertility Centre | 2014-01-01 |
| A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer. (NCT02055066) | argenx | 2014-01-01 |
| Dose Escalation Study of Intravenous Baclofen in Healthy Adult Volunteers (NCT01931319) | University of Minnesota | 2014-01-01 |
| An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor (NCT02015507) | Vertex Pharmaceuticals Incorporated | 2014-01-01 |
| Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB (NCT02496013) | Peking Union Medical College Hospital | 2014-01-01 |
| Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI (NCT02066870) | Betta Pharmaceuticals Co., Ltd. | 2014-01-01 |
| Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma. (NCT02330978) | University of Sao Paulo | 2014-01-01 |
| Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study (NCT02034838) | Ottawa Hospital Research Institute | 2014-01-01 |
| Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C (NCT01899092) | Tacere Therapeutics, Inc. | 2014-01-01 |
| HomeTech Healthy Lifestyle Program for Mothers With Young Children (NCT01819987) | University of California, San Francisco | 2014-01-01 |
| A Trial of Bedside Placement of Nasal Jejunal Tube Confirmed by Ultrasound Compared to Placement by Endoscope in Patients With SAP (NCT02456155) | Li Gang | 2014-01-01 |
| Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted Conditions (NCT02041273) | Pfizer | 2014-01-01 |
| A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta (NCT02019602) | UCB BIOSCIENCES, Inc. | 2014-01-01 |
| Effect of Chlorhexidine Gel on Bacterial Count During Fixed Orthodontic Treatment (NCT02001311) | King Abdulaziz University | 2014-01-01 |
| A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration (NCT02022501) | Santen Inc. | 2014-01-01 |
| Clinical Trial to Characterize Pharmacokinetic-pharmacodynamic (PKPD) of Prasugrel 10 mg or 30 mg in Healthy Volunteers (NCT02075268) | Asan Medical Center | 2014-01-01 |
| Metabolism and Excretion of [14C]-Rigosertib After Infusion to Volunteers (NCT02030639) | Traws Pharma, Inc. | 2014-01-01 |
| A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain (NCT02036281) | University of Texas Southwestern Medical Center | 2014-01-01 |
| A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine (NCT02128321) | Astellas Pharma Global Development, Inc. | 2014-01-01 |
| Effectiveness of Perineural Clonidine as an Adjuvant With Ropivacaine for Popliteal Nerve Block in Patients Undergoing Foot and Ankle Surgery (NCT01986751) | University of Alabama at Birmingham | 2014-01-01 |
| 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease (NCT02031198) | Axon Neuroscience SE | 2014-01-01 |
| Effect of Local Application of Boron on Diabetic Foot Ulcers (NCT02087215) | Bezmialem Vakif University | 2014-01-01 |
| Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery (NCT01954732) | Case Comprehensive Cancer Center | 2014-01-01 |
| PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors (NCT02022982) | Dana-Farber Cancer Institute | 2014-01-01 |
| A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance (NCT01953081) | Takeda | 2014-01-01 |
| Efficacy of Pirfenidone Plus MODD in Diabetic Foot Ulcers (NCT02632877) | University of Guadalajara | 2014-01-01 |
| DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study (NCT02379507) | Medicus Research, LLC | 2014-01-01 |
| A Pilot Study Of Riluzole In Patients With Post Traumatic Stress Disorder (PTSD) (NCT02019940) | Yale University | 2014-01-01 |
| Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy Subjects (NCT02028780) | Boehringer Ingelheim | 2014-01-01 |
| Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients (NCT03113812) | Araclon Biotech S.L. | 2014-01-01 |
| Phenylbutyrate Response as a Biomarker for Alpha-synuclein Clearance From the Brain (NCT02046434) | University of Colorado, Denver | 2014-01-01 |
| PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers (NCT02039817) | Conatus Pharmaceuticals Inc. | 2014-01-01 |
| Pharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With Food (NCT02039258) | Janssen Research & Development, LLC | 2014-01-01 |
| A Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy Volunteers (NCT02053454) | Alnylam Pharmaceuticals | 2014-01-01 |
| Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease (NCT02055625) | Karolinska Institutet | 2014-01-01 |
| Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts (NCT03415477) | Peking University People's Hospital | 2014-01-01 |
| Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers (NCT02044367) | Boehringer Ingelheim | 2014-01-01 |
| Derivation of Tumor Specific Hybridomas (NCT01702792) | Dartmouth-Hitchcock Medical Center | 2014-01-01 |
| A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 Diabetes (NCT02033239) | Novo Nordisk A/S | 2014-01-01 |
| Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients (NCT02040064) | Gustave Roussy, Cancer Campus, Grand Paris | 2014-01-01 |
| Non-invasive Current Stimulation for Restoration of Vision (NCT04008589) | University of Magdeburg | 2014-01-01 |
| Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS) (NCT02093429) | Incyte Corporation | 2014-01-01 |
| Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802 (NCT02041715) | Arbutus Biopharma Corporation | 2014-01-01 |
| Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy (NCT01728480) | Roswell Park Cancer Institute | 2014-01-01 |
| 3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma (NCT02057445) | New York Medical College | 2014-01-01 |
| Physiological Study of Low-frequency HFO/HFO-TGI and High-frequency HFO (NCT02027129) | University of Athens | 2014-01-01 |
| Effect of Hepatic Impairment on LDK378 Pharmacokinetics (NCT01950481) | Novartis Pharmaceuticals | 2014-01-01 |
| Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction (NCT01407900) | John A. Schirger | 2014-01-01 |
| A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01) (NCT02031991) | Pfizer | 2014-01-01 |
| A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 (NCT02018510) | Rockefeller University | 2014-01-01 |
| Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients (NCT02472002) | Assistance Publique - Hôpitaux de Paris | 2014-01-01 |
| A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects (NCT02174822) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2014-01-01 |
| A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453 (NCT02052687) | Novartis Pharmaceuticals | 2014-01-01 |
| A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors (NCT02004106) | Hoffmann-La Roche | 2013-12-31 |
| A Study of TAK-659 in Adult Participants With Advanced Solid Tumor and Lymphoma Malignancies (NCT02000934) | Calithera Biosciences, Inc | 2013-12-31 |
| RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER (NCT02029729) | Biogen | 2013-12-31 |
| Comparison of Two Formulations of Androxal (NCT01984398) | Repros Therapeutics Inc. | 2013-12-31 |
| Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC) (NCT01999985) | H. Lee Moffitt Cancer Center and Research Institute | 2013-12-31 |
| RTA 408 Lotion in Healthy Volunteers (NCT02029716) | Biogen | 2013-12-31 |
| A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer (NCT02025192) | Seagen Inc. | 2013-12-31 |
| An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients (NCT02103426) | Astellas Pharma Global Development, Inc. | 2013-12-30 |
| Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib) (NCT01976741) | Bayer | 2013-12-30 |
| A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation (NCT01859026) | H. Lee Moffitt Cancer Center and Research Institute | 2013-12-30 |
| Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects (NCT02022748) | AstraZeneca | 2013-12-29 |
| Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors (NCT01988896) | Hoffmann-La Roche | 2013-12-27 |
| Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018) (NCT02014636) | Novartis Pharmaceuticals | 2013-12-27 |
| Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene (NCT01875237) | M.D. Anderson Cancer Center | 2013-12-27 |
| Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device (NCT02331381) | Washington University School of Medicine | 2013-12-26 |
| Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C. (NCT02014571) | GlaxoSmithKline | 2013-12-26 |
| The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168) (NCT01980940) | Organon and Co | 2013-12-23 |
| Safety, Tolerability and Pharmacokinetics of SP-8203 (NCT01757795) | Shin Poong Pharmaceutical Co. Ltd. | 2013-12-23 |
| Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT) (NCT01982955) | Merck KGaA, Darmstadt, Germany | 2013-12-23 |
| Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases (NCT01934790) | Bayer | 2013-12-22 |
| An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma (NCT01969695) | AbbVie | 2013-12-20 |
| Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis. (NCT02000453) | GlaxoSmithKline | 2013-12-20 |
| Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone (NCT02027961) | MedImmune LLC | 2013-12-20 |
| A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors (NCT01954043) | GlaxoSmithKline | 2013-12-20 |
| A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies (NCT02013804) | MedImmune LLC | 2013-12-19 |
| Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery (NCT02067884) | University of Southern California | 2013-12-19 |
| A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab (NCT01975831) | Ludwig Institute for Cancer Research | 2013-12-19 |
| A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide (NCT03889145) | IlDong Pharmaceutical Co Ltd | 2013-12-19 |
| CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200) (NCT02043665) | Viralytics | 2013-12-18 |
| A Study of LY2835219 in Japanese Participants With Advanced Cancer (NCT02014129) | Eli Lilly and Company | 2013-12-18 |
| Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP). (NCT02009761) | Boehringer Ingelheim | 2013-12-18 |
| Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma (NCT02031419) | Celgene | 2013-12-18 |
| Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL) (NCT01891981) | M.D. Anderson Cancer Center | 2013-12-17 |